litlas
Log inCreate account

David M. Berman

Active 1977–2025

101
Papers
24,704
Citations
71
h-index
92
i10-index

Citations

Citations per year for David M. Berman1967: 1 citations1979: 1 citations1980: 1 citations1985: 3 citations1986: 2 citations1991: 2 citations1992: 18 citations1993: 12 citations1994: 17 citations1995: 14 citations1996: 18 citations1997: 76 citations1998: 114 citations1999: 157 citations2000: 137 citations2001: 89 citations2002: 72 citations2003: 90 citations2004: 148 citations2005: 207 citations2006: 260 citations2007: 266 citations2008: 266 citations2009: 252 citations2010: 300 citations2011: 260 citations2012: 263 citations2013: 288 citations2014: 277 citations2015: 324 citations2016: 344 citations2017: 342 citations2018: 290 citations2019: 828 citations2020: 801 citations2021: 688 citations2022: 470 citations2023: 314 citations2024: 476 citations2025: 188 citations2026: 12 citations1968–1978: no citations, so these years are not shown1981–1984: no citations, so these years are not shown1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,751 citing papers, 33.8% of this breakdownChina: 965 citing papers, 8.7% of this breakdownUnited Kingdom: 639 citing papers, 5.8% of this breakdownGermany: 592 citing papers, 5.3% of this breakdownItaly: 497 citing papers, 4.5% of this breakdownFrance: 430 citing papers, 3.9% of this breakdownCanada: 416 citing papers, 3.7% of this breakdownJapan: 323 citing papers, 2.9% of this breakdownSpain: 322 citing papers, 2.9% of this breakdownNetherlands: 292 citing papers, 2.6% of this breakdownAustralia: 288 citing papers, 2.6% of this breakdownSwitzerland: 240 citing papers, 2.2% of this breakdown
0%33.8%Other 21.1%

Institutions

Fields

  • Medicine50%
  • Biochemistry, Genetics and Molecular Biology35.8%
  • Immunology and Microbiology8.1%
  • Computer Science1.7%
  • Neuroscience1.2%
  • Engineering1%
  • Other2.2%

Topics

  • Cancer Immunotherapy and Biomarkers9.3%
  • Immunotherapy and Immune Responses6%
  • CAR-T cell therapy research4.6%
  • Epigenetics and DNA Methylation4.5%
  • Hedgehog Signaling Pathway Studies3.4%
  • Immune Cell Function and Interaction2.8%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

    Authors: Dirk Schadendorf, F. Stephen Hodi, Caroline Robert, Jeffrey S. Weber, Kim Margolin, Omid Hamid, Debra A. Patt, Tai‐Tsang Chen, David M. Berman, Jedd D. Wolchok - Journal of Clinical Oncology 2015 cited by 2,122

  2. Clinical implications of PTEN loss in prostate cancer

    Authors: Tamara Jamaspishvili, David M. Berman, Ashley E. Ross, Howard I. Scher, Angelo M. De Marzo, Jeremy A. Squire, Tamara L. Lotan - Nature Reviews Urology 2018 cited by 658

  3. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    Authors: Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai S. Kammula, D E White, Sharon Mavroukakis, Linda Rogers, Gerald Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea‐Banacloche, Michael R. Robinson, David M. Berman, Armando Filie, Andrea Abati, Steven A. Rosenberg - Journal of Clinical Oncology 2005 cited by 1,628

  4. The Proteogenomic Landscape of Curable Prostate Cancer

    Authors: Ankit Sinha, Vincent Huang, Julie Livingstone, Jenny Wang, Natalie S. Fox, Natalie J. Kurganovs, Vladimir Ignatchenko, Katharina Fritsch, Nilgun Donmez, Lawrence E. Heisler, Yu-Jia Shiah, Cindy Q. Yao, Javier A. Alfaro, Stas Volik, Anna Lapuk, Michael Fraser, Ken J. Kron, Alex Murison, Mathieu Lupien, Cenk Sahinalp, Colin C. Collins, Bernard Têtu, Mehdi Masoomian, David M. Berman, Theodorus van der Kwast, Robert G. Bristow, Thomas Kislinger, Paul C. Boutros - Cancer Cell 2019 cited by 278

  5. Evolving synergistic combinations of targeted immunotherapies to combat cancer

    Authors: Ignacio Melero, David M. Berman, M. Ángela Aznar, Alan J. Korman, José Luis Perez‐Gracia, John B.A.G. Haanen - Nature reviews. Cancer 2015 cited by 644

  6. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

    Authors: Joyce E. Ohm, Kelly M. McGarvey, Xiaobing Yu, Linzhao Cheng, Kornel E. Schuebel, Leslie Cope, Helai P. Mohammad, Wei Chen, Vincent C. Daniel, Wayne Yu, David M. Berman, Thomas Jenuwein, Kevin Pruitt, Saul J. Sharkis, D. Neil Watkins, James G. Herman, Stephen B. Baylin - Nature Genetics 2007 cited by 1,148

  7. An immune-active tumor microenvironment favors clinical response to ipilimumab

    Authors: Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang, Omid Hamid, Henrik Schmidt, John Cogswell, Suresh Alaparthy, David M. Berman, Maria Jure–Kunkel, Nathan O. Siemers, Jeffrey R. Jackson, Vafa Shahabi - Cancer Immunology Immunotherapy 2011 cited by 777

  8. A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

    Authors: Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M. Hyams, Henry Gómez, Lars Bastholt, Scott D. Chasalow, David M. Berman - Journal of Translational Medicine 2011 cited by 531

  9. Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up

    Authors: Laurence Klotz, Gregory R. Pond, Andrew Loblaw, Linda Sugar, Madeline Moussa, David M. Berman, Theodorus van der Kwast, Danny Vesprini, Laurent Milot, Marlene Kebabdjian, Neil Fleshner, Sangheet Ghai, Joseph L. Chin, Masoom A. Haider - European Urology 2019 cited by 153

  10. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

    Authors: Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, Walter J. Urba, Caroline Robert, Steven O’Day, Axel Hoos, Rachel Humphrey, David M. Berman, Nils Lönberg, Alan J. Korman - Annals of the New York Academy of Sciences 2013 cited by 307

  11. Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events

    Authors: Vafa Shahabi, David M. Berman, Scott D. Chasalow, Lisu Wang, Zenta Tsuchihashi, Beihong Hu, Lisa Panting, Maria Jure–Kunkel, Rui‐Ru Ji - Journal of Translational Medicine 2013 cited by 173

  12. Hedgehog signalling in prostate regeneration, neoplasia and metastasis

    Authors: Sunil Karhadkar, G. Steven Bova, Nadia M. Abdallah, Surajit Dhara, Dale R. Gardner, Anirban Maitra, John T. Isaacs, David M. Berman, Philip A. Beachy - Nature 2004 cited by 947

  13. A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

    Authors: Jeffrey S. Weber, John A. Thompson, Omid Hamid, David R. Minor, Asim Amin, Ilan G. Ron, Ruggero Ridolfi, Hazem Assi, Anthony Maraveyas, David M. Berman, Jonathan Siegel, Steven O’Day - Clinical Cancer Research 2009 cited by 567

  14. Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer

    Authors: Madhuri Koti, Amanda Shuo Xu, Kevin Ren, Kash Visram, Runhan Ren, David M. Berman, D. Robert Siemens - Bladder Cancer 2017 cited by 75

  15. Graphs with homeomorphically irreducible spanning trees

    Authors: Michael O. Albertson, David M. Berman, Joan P. Hutchinson, Carsten Thomassen - Journal of Graph Theory, J. Graph Theory 1990 cited by 40

  16. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation

    Authors: Elena J. Ladas, Monica Bhatia, Lu Chen, Eric Sandler, Aleksandra Petrović, David M. Berman, Frances Hamblin, Michael Gates, R. Hawks, Lillian Sung, Michael L. Nieder - Bone Marrow Transplantation 2015 cited by 132

  17. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

    Authors: David M. Berman, Sunil Karhadkar, Anirban Maitra, Rocío Montes de, Meg R. Gerstenblith, Kimberly J. Briggs, Antony R. Parker, Yutaka Shimada, James R. Eshleman, D. Neil Watkins, Philip A. Beachy - Nature 2003 cited by 1,257

  18. Tissue repair and stem cell renewal in carcinogenesis

    Authors: Philip A. Beachy, Sunil Karhadkar, David M. Berman - Nature 2004 cited by 1,211

  19. GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α Subunits

    Authors: David M. Berman, Thomas M. Wilkie, Alfred G. Gilman - Cell 1996 cited by 742

  20. Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy

    Authors: Axel Hoos, Ramy Ibrahim, Alan J. Korman, Kald Abdallah, David M. Berman, Vafa Shahabi, Kevin M. Chin, Renzo Canetta, Rachel Humphrey - Seminars in Oncology 2010 cited by 239

  21. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma

    Authors: Theodorus van der Kwast, Fredrik Liedberg, Peter C. Black, Ashish M. Kamat, Bas W.G. van Rhijn, Ferrán Algaba, David M. Berman, Arndt Hartmann, Antonio López-Beltrán, Hemamali Samaratunga, Murali Varma, Liang Cheng - European Urology Focus 2021 cited by 45

  22. Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis

    Authors: J.J.G. Tesmer, David M. Berman, Alfred G. Gilman, Stephen R. Sprang - Cell 1997 cited by 790

  23. Molecular profiling in muscle‐invasive bladder cancer: more than the sum of its parts

    Authors: Gottfrid Sjödahl, Chelsea Jackson, John M.S. Bartlett, D. Robert Siemens, David M. Berman - The Journal of Pathology 2019 cited by 89

  24. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells

    Authors: Thiago Vidotto, Fabiano Pinto Saggioro, Tamara Jamaspishvili, Deise L. Chesca, Clarissa Gondim Picanço de Albuquerque, Rodolfo Borges dos Reis, Charles H. Graham, David M. Berman, D. Robert Siemens, Jeremy A. Squire, Madhuri Koti - The Prostate 2019 cited by 86